Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
28.04.23 | Vantiva - Good broadband growth supports FY23 prospects | 382 | Edison Investment Research | Vantiva's Q1 trading update shows the group is on track to meet FY23 guidance, with a strong performance from the larger Connected Home (CH) segment (80% of Q123 revenue), and a more difficult trading... ► Artikel lesen | |
28.04.23 | Immix Biopharma - CAR-T treatment continues to show promise | 428 | Edison Investment Research | Immix Biopharma continues to share encouraging data from the Phase Ib/II open-label NEXICART-1 trial. This study is investigating NXC-201, a CAR-T therapy, for the treatment of multiple myeloma (MM)... ► Artikel lesen | |
28.04.23 | Respiri - Commercialisation at the forefront | 350 | Edison Investment Research | Respiri released its Q323 activity report, updating investors on key highlights during the quarter. The period was marked by continued expansion of the company's commercial footprint in the US, which... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
GAMESTOP | 335 |
EVOTEC | 303 |
TUI | 215 |
NVIDIA | 180 |
DEUTSCHE BANK | 175 |
BAYER | 161 |
PLUG POWER | 146 |
NEL | 139 |
RHEINMETALL | 135 |
SIEMENS ENERGY | 115 |
BARRICK GOLD | 111 |
COMMERZBANK | 108 |
BASF | 107 |
TESLA | 106 |
VOLKSWAGEN | 96 |
RWE | 94 |
BYD | 92 |
DEUTSCHE LUFTHANSA | 87 |
ALLIANZ | 85 |
MERCEDES-BENZ | 81 |
RENK GROUP | 81 |
DEUTSCHE TELEKOM | 78 |
HEIDELBERGER DRUCK | 77 |
AIXTRON SE | 75 |
REDCARE PHARMACY | 73 |